CRISPR Therapeutics AG - CRSP

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$4.056B

QoQ value delta ($000)

-$301.6M (-6.92%)

Implied price effect (QoQ)

-9.83%

Total shares

85,002,957

QoQ shares delta

+2,657,405 (+3.23%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 497 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
ARK Investment Management LLC	538,189	11,313,623	4.19%
BlackRock, Inc.	365,341	7,680,073	0.01%
Orbis Allan Gray Ltd	290,462	6,106,011	1.23%
Capital World Investors	224,770	4,725,037	0.03%
STATE STREET CORP	189,447	3,982,500	0.01%
GSK plc	153,205	3,220,627	25.57%
T. Rowe Price Investment Management, Inc.	140,455	2,952,595	0.1%
VANGUARD GROUP INC	118,954	2,268,394	0.0%
GEODE CAPITAL MANAGEMENT, LLC	113,102	2,377,164	0.01%
SR ONE CAPITAL MANAGEMENT, LP	96,983	2,038,763	10.59%
FMR LLC	92,984	1,954,694	0.0%
Sumitomo Mitsui Trust Group, Inc.	88,188	1,853,875	0.06%
Amova Asset Management Americas, Inc.	88,188	1,853,875	1.25%
UBS Group AG	83,843	1,762,530	0.01%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	78,352	1,647,106	0.01%
TWO SIGMA INVESTMENTS, LP	70,548	1,483,051	0.06%
EcoR1 Capital, LLC	66,087	1,389,276	2.8%
CITADEL ADVISORS LLC	64,103	1,347,552	0.01%
Capital International Investors	56,455	1,186,794	0.01%
VANGUARD CAPITAL MANAGEMENT LLC	54,350	1,142,543	0.0%
NEA Management Company, LLC	50,356	1,058,570	2.86%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	49,441	1,039,349	0.01%
BANK OF AMERICA CORP /DE/	46,764	983,072	0.0%
LOOMIS SAYLES & CO L P	46,054	968,135	0.06%
JANE STREET GROUP, LLC	39,392	828,100	0.01%